The store will not work correctly when cookies are disabled.
7-[3-(aminomethyl)phenyl]-4-methyl-quinolin-2-amine Dihydrochloride
ID: ALA4483429
PubChem CID: 155540835
Max Phase: Preclinical
Molecular Formula: C17H19Cl2N3
Molecular Weight: 263.34
Molecule Type: Unknown
This compound is available for customization.
Associated Items:
Names and Identifiers
Canonical SMILES: Cc1cc(N)nc2cc(-c3cccc(CN)c3)ccc12.Cl.Cl
Standard InChI: InChI=1S/C17H17N3.2ClH/c1-11-7-17(19)20-16-9-14(5-6-15(11)16)13-4-2-3-12(8-13)10-18;;/h2-9H,10,18H2,1H3,(H2,19,20);2*1H
Standard InChI Key: SGPUJJMWTAMZCO-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 22 0 0 0 0 0 0 0 0999 V2000
25.1446 -28.7384 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
24.6108 -26.1179 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.6096 -26.9480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.3273 -27.3644 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.3255 -25.7059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0439 -26.1142 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.0446 -26.9439 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7629 -27.3583 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4809 -26.9401 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4761 -26.1074 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.7572 -25.7008 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
23.8919 -27.3635 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
25.3231 -24.8823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1921 -27.3450 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1947 -28.1697 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.9091 -28.5780 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6213 -28.1628 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6148 -27.3349 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8998 -26.9303 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.3246 -26.9172 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0413 -27.3230 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.2660 -28.8632 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 3 2 0
3 4 1 0
4 7 2 0
6 5 2 0
5 2 1 0
6 7 1 0
7 8 1 0
8 9 2 0
9 10 1 0
10 11 2 0
11 6 1 0
3 12 1 0
5 13 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 18 1 0
18 19 2 0
19 14 1 0
9 14 1 0
18 20 1 0
20 21 1 0
M END
Associated Targets(Human)
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 263.34 | Molecular Weight (Monoisotopic): 263.1422 | AlogP: 3.25 | #Rotatable Bonds: 2 |
Polar Surface Area: 64.93 | Molecular Species: BASE | HBA: 3 | HBD: 2 |
#RO5 Violations: ┄ | HBA (Lipinski): 3 | HBD (Lipinski): 4 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 9.24 | CX LogP: 3.18 | CX LogD: 1.27 |
Aromatic Rings: 3 | Heavy Atoms: 20 | QED Weighted: 0.75 | Np Likeness Score: -0.35 |
References
1. Cinelli MA, Reidl CT, Li H, Chreifi G, Poulos TL, Silverman RB.. (2020) First Contact: 7-Phenyl-2-Aminoquinolines, Potent and Selective Neuronal Nitric Oxide Synthase Inhibitors That Target an Isoform-Specific Aspartate., 63 (9): [PMID:32302123] [10.1021/acs.jmedchem.9b01573] |